SCHEDULE 13D/A

Fate Therapeutics Inc

Common Stock, par value $0.001 per share · CUSIP: 31189P102

Event date: 2026-11-05

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Redmile Group, LLCReported CIK 0001425738

  Shares: 19,164,572.00 · Class: 14.99%

• Jeremy C. Green

  Shares: 19,164,572.00 · Class: 14.99%

• RedCo II Offshore SPV LLC

  Shares: 10,144,307.00 · Class: 8.12%

• Redmile Capital Offshore II Master Fund, Ltd.

  Shares: 6,426,298.00 · Class: 5.03%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.